Julian Dye
Dr/CEO, Oxartis Limited
Oxartis is developing affordable tissue-regenerative scaffold technology from Oxford University. The lead product, ProMatrix BioDerm, will transform outcomes for millions of patients by accelerating skin reconstruction while preventing scarring.
Events Julian Dye has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026